Ignite Creation Date:
2024-05-05 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00352859
Status:
TERMINATED
Last Update Posted:
2014-12-30
First Post:
2006-07-14
Brief Title:
Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib
Sponsor:
Organization:
Bayer